Prognostic value of a Non-invasive surrogate for right ventricular pressure-volume loops

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22554

Enrollment

250

Registered

2015-05-18

Start date

2015-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonal arterial hypertension (PAH)

Interventions

A questionnaire regarding physical health, hospital or general practitioner visits and change in treatment will be send annually.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with PAH 2. NICE-group 1, NYHA classification II-IV 3. Presence of an echocardiographic assessment 4. ≥ 18 years of age; 5. Mentally able/allowed to give informed consent.

Exclusion criteria

Exclusion criteria: 1. Absence of an echocardiographic assessment 2. Different classification of PAH 3. Not willing to participate in this research 4. Absence of contact information

Design outcomes

Primary

Measure	Time frame
1. Mortality 2. Morbidity In case of morbidity secondary cardiovascular diseases, newly prescribed medication and surgery events will be monitored.	—

Contacts

Public ContactHugo Hulshof

Phililps van Leijdenlaan 15

Hugo.G.Hulshof@radboudumc.nltelephone +31 (024) 3614209

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)